| Ms Amy C Bignault, MS CCC-SLP | |
|
100 Foxcroft Dr., Doylestown, PA 18901 | |
| (630) 290-1091 | |
| Not Available |
| Full Name | Ms Amy C Bignault |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 100 Foxcroft Dr., Doylestown, Pennsylvania |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174760029 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 146.005581 (Illinois) | Secondary |
| 235Z00000X | Speech-language Pathologist | 56010136 (Pennsylvania) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ms Amy C Bignault, MS CCC-SLP 100 Foxcroft Dr., Doylestown, PA 18901 Ph: (630) 290-1091 | Ms Amy C Bignault, MS CCC-SLP 100 Foxcroft Dr., Doylestown, PA 18901 Ph: (630) 290-1091 |
News Archive
A new survey, released today (22 March 2016) by the Royal Medical Benevolent Fund, highlights the overwhelming concern amongst doctors about the state of their mental health and wellbeing as a result of working under increasing pressure and scrutiny.
A synthetic, soft tissue retina developed by an Oxford University student could offer fresh hope to visually impaired people.
Trius Therapeutics, Inc., today announced the award of a $28 million contract from the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health, for the development of novel antibiotics directed against multiple Gram-negative bacterial pathogens.
A new study using ovarian cancer cell lines shows promise in treating the deadly disease by combining the chemotherapy drug cisplatin with an aspirin-like compound to make recurrent cancer cells less resistant to the chemotherapy.
A recent study conducted at the Medical University of Graz, Austria, has revealed that the number of naïve B cells in the blood could independently predict the magnitude of immune response induced by coronavirus disease 2019 (COVID-19) vaccines in immunocompromised patients. The study is currently available on the medRxiv* preprint server.
› Verified 3 days ago
Mr. Charles William Belt, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 350 South Main Street, Suite 315, Doylestown, PA 18901 Phone: 215-489-8760 Fax: 215-489-8766 | |
Kendra Wheeler, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 101 Progress Dr, Doylestown, PA 18901 Phone: 215-622-5004 | |
Mr. Phillip A Hernandez Jr., MS CCCSLPL Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 350 South Main Street, Suite 315, Doylestown, PA 18901 Phone: 215-489-8760 Fax: 215-489-8766 | |
Stefanie Brown, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 705 N Shady Retreat Rd, Doylestown, PA 18901 Phone: 800-770-4822 | |
Rachel Friel, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 739 N Easton Rd Ste 202, Doylestown, PA 18902 Phone: 215-345-5960 | |
Morley K Ewing, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 140 Short Road, Doylestown, PA 18901 Phone: 215-340-9869 | |
Julianna Magazzeni, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 777 Ferry Rd, Doylestown, PA 18901 Phone: 215-340-5228 |